A recent study utilizing a breast cancer model with genetic loss or pharmacological inhibition of CD73 resulted in far fewer and less invasive organoids in vitro and decreased lung metastasis when injected into an immune competent mouse model. The gene discussed is NT5E; the disease is breast carcinoma.